Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis

Publication date: Available online 19 March 2021Source: Best Practice & Research Clinical RheumatologyAuthor(s): Martin Aringer, Gabriela Riemekasten

Source: Best Practice and Research Clinical Rheumatology - March 19, 2021 Category: Rheumatology Source Type: research